IPEC calls on FDA to establish new review process for novel excipients
By Zachary Brennan+, 22-Jul-2015
As part of a push to bring more novel excipients to market, IPEC-Americas is calling on the FDA to create a new regulatory review process that could relieve some of the uncertainty around the use of new excipients.